| PAM50 breast cancer subtyping by RT-qPCR and concordance with standard clinical molecular markers RRL Bastien, Á Rodríguez-Lescure, MTW Ebbert, A Prat, B Munárriz, ... BMC medical genomics 5, 1-12, 2012 | 397 | 2012 |
| Adjuvant docetaxel for high-risk, node-negative breast cancer M Martín, MA Seguí, A Antón, A Ruiz, M Ramos, E Adrover, I Aranda, ... New England Journal of Medicine 363 (23), 2200-2210, 2010 | 251 | 2010 |
| Detection of BRAF V600E mutation in colorectal cancer: comparison of automatic sequencing and real-time chemistry methodology S Benlloch, A Payá, C Alenda, X Bessa, M Andreu, R Jover, A Castells, ... The Journal of Molecular Diagnostics 8 (5), 540-543, 2006 | 183 | 2006 |
| Acute human brain responses to intracortical microelectrode arrays: challenges and future prospects E Fernández, B Greger, PA House, I Aranda, C Botella, J Albisua, ... Frontiers in neuroengineering 7, 24, 2014 | 156 | 2014 |
| Prevalence of Lynch syndrome among patients with newly diagnosed endometrial cancers C Egoavil, C Alenda, A Castillejo, A Paya, G Peiro, AB Sánchez-Heras, ... PLoS one 8 (11), e79737, 2013 | 128 | 2013 |
| The cavitated accessory uterine mass: a Müllerian anomaly in women with an otherwise normal uterus P Acién, M Acién, F Fernández, MJ Mayol, I Aranda Obstetrics & Gynecology 116 (5), 1101-1109, 2010 | 101 | 2010 |
| Biochemical and cytologic characteristics of pleural effusions secondary to pulmonary embolism SR Candeira, LH Blasco, MJ Soler, A Munoz, I Aranda Chest 121 (2), 465-469, 2002 | 96 | 2002 |
| Immunohistochemical analysis of tumor angiogenic factors in human pituitary adenomas M Niveiro, FI Aranda, G Peiró, C Alenda, A Picó Human pathology 36 (10), 1090-1095, 2005 | 87 | 2005 |
| Idiopathic organizing pneumonia: a relapsing disease: 19 years of experience in a hospital setting E Barroso, L Hernandez, J Gil, R Garcia, I Aranda, S Romero Respiration 74 (6), 624-631, 2007 | 80 | 2007 |
| Phyllodes tumor in ectopic breast tissue of the vulva MT Chulia, A Paya, M Niveiro, S Ceballos, FI Aranda International Journal of Surgical Pathology 9 (1), 81-83, 2001 | 69 | 2001 |
| Organizing pneumonia in textile printing workers: a clinical description S Romero, L Hernández, J Gil, I Aranda, C Martín, J Sanchez-Payá European Respiratory Journal 11 (2), 265-271, 1998 | 66 | 1998 |
| Defective mismatch-repair colorectal cancer: clinicopathologic characteristics and usefulness of immunohistochemical analysis for diagnosis R Jover, A Payá, C Alenda, MJ Poveda, G Peiró, FI Aranda, ... American journal of clinical pathology 122 (3), 389-394, 2004 | 64 | 2004 |
| Phyllodes tumor of the breast: an immunohistochemical study of 28 cases with special attention to the role of myofibroblasts FI Aranda, JB Laforga, JI Lopez Pathology-Research and Practice 190 (5), 474-481, 1994 | 59 | 1994 |
| Assessment of a new ROS1 immunohistochemistry clone (SP384) for the identification of ROS1 rearrangements in patients with non–small cell lung carcinoma: the ROSING study E Conde, S Hernandez, R Martinez, B Angulo, J De Castro, ... Journal of Thoracic Oncology 14 (12), 2120-2132, 2019 | 58 | 2019 |
| Angiogenic index: a new method for assessing microvascularity in breast carcinoma with possible prognostic implications JBM Laforga, FI Aranda The Breast Journal 6 (2), 103-107, 2000 | 57 | 2000 |
| Ectopic growth hormone‐releasing hormone secretion by thymic carcinoid tumour E Boix, A Pico, R Pinedo, I Aranda, K Kovacs Clinical endocrinology 57 (1), 131-134, 2002 | 55 | 2002 |
| Follicular bronchiolitis: clinical and pathologic findings in six patients S Romero, E Barroso, J Gil, I Aranda, S Alonso, E Garcia-Pachon Lung 181, 309-319, 2003 | 54 | 2003 |
| Increased insulin-like growth factor-1 receptor mRNA expression predicts poor survival in immunophenotypes of early breast carcinoma G Peiro, E Adrover, L Sánchez-Tejada, E Lerma, M Planelles, ... Modern Pathology 24 (2), 201-208, 2011 | 49 | 2011 |
| Organizing pneumonia adjacent to lung cancer: frequency and clinico-pathologic features S Romero, E Barroso, M Rodriguez-Paniagua, FI Aranda Lung Cancer 35 (2), 195-201, 2002 | 49 | 2002 |
| Exon 20 PIK3CA mutations decreases survival in aggressive (HER-2 positive) breast carcinomas E Lerma, L Catasus, A Gallardo, G Peiro, C Alonso, I Aranda, A Barnadas, ... Virchows Archiv 453, 133-139, 2008 | 47 | 2008 |
